Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CLN3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CLN3 gene encoding a lysosomal transmembrane protein defective in juvenile neuronal ceroid lipofuscinosis (Batten disease)
No AI portrait yet
| Gene Symbol | CLN3 |
| Aliases | Batten disease, Battenin |
| Function | encodes a lysosomal/endosomal transmembrane protein that is critical for neuronal function and survival. |
| Molecular Weight | 48 kDa |
| Amino Acids | 438 aa |
| Ensembl ID | ENSG00000158966 |
| GeneCards | CLN3 |
| Human Protein Atlas | CLN3 |
| Associated Diseases | Cancer, Cln3 Disease, Ms, neurodegeneration |
| KG Connections | 69 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
CLN3["CLN3"]
Als{"Als"}
CLN3 -->|"expressed in"| Als
Cancer{"Cancer"}
CLN3 -->|"expressed in"| Cancer
Tumor{"Tumor"}
CLN3 -->|"expressed in"| Tumor
Inflammation{"Inflammation"}
CLN3 -->|"therapeutic target"| Inflammation
Alzheimer{"Alzheimer"}
CLN3 -->|"therapeutic target"| Alzheimer
CLN3 -->|"therapeutic target"| Als
Neuroinflammation{"Neuroinflammation"}
CLN3 -->|"therapeutic target"| Neuroinflammation
Ms{"Ms"}
CLN3 -->|"therapeutic target"| Ms
Aging{"Aging"}
CLN3 -->|"biomarker for"| Aging
CLN3 -->|"interacts with"| Ms
GABARAPL2["GABARAPL2"]
CLN3 -->|"expressed in"| GABARAPL2
SNX2["SNX2"]
CLN3 -->|"expressed in"| SNX2
style CLN3 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Cln3 Disease | causes | disease | 0.95 |
| Cancer | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Aging | biomarker_for | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| GABARAPL2 | expressed_in | gene | 0.60 |
| SNX2 | expressed_in | gene | 0.60 |
| ATG10 | expressed_in | gene | 0.60 |
| WIPI2 | expressed_in | gene | 0.60 |
| CXCL10 | therapeutic_target | gene | 0.60 |
| C1QA | therapeutic_target | gene | 0.60 |
| TAU | therapeutic_target | gene | 0.60 |
| DRD1 | therapeutic_target | gene | 0.60 |
| GPNMB | biomarker_for | gene | 0.60 |
| NLRP3 | therapeutic_target | gene | 0.60 |
| CX3CR1 | biomarker_for | gene | 0.60 |
| P2RY12 | biomarker_for | gene | 0.60 |
| CANCER | expressed_in | gene | 0.60 |
| neurodegeneration | associated_with | disease | 0.60 |
| DMSO | therapeutic_target | gene | 0.60 |
| ERK | therapeutic_target | gene | 0.60 |
| MICROGLIA | biomarker_for | gene | 0.60 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.60 |
| ASTROCYTES | therapeutic_target | gene | 0.60 |
| TAU PATHOLOGY | therapeutic_target | gene | 0.60 |
| NEUROINFLAMMATION | therapeutic_target | gene | 0.60 |
| DISEASE-ASSOCIATED MICROGLIA | therapeutic_target | gene | 0.60 |
| App | associated_with | protein | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| AND | biomarker_for | gene | 0.60 |
| Stem Cell | associated_with | cell_type | 0.60 |
| Neuron | associated_with | cell_type | 0.60 |
| neurodegeneration | causes | disease | 0.60 |
| Stem Cell | expressed_in | cell_type | 0.55 |
| Neuron | expressed_in | cell_type | 0.55 |
| disease | expressed_in | disease | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEUROINFLAMMATION | therapeutic_target | gene | 0.60 |
| MICROGLIA | biomarker_for | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| AND | biomarker_for | gene | 0.60 |
| DMSO | therapeutic_target | gene | 0.60 |
| TAU PATHOLOGY | therapeutic_target | gene | 0.60 |
| ERK | therapeutic_target | gene | 0.60 |
| NLRP3 | therapeutic_target | gene | 0.60 |
| CXCL10 | therapeutic_target | gene | 0.60 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.60 |
| DISEASE-ASSOCIATED MICROGLIA | therapeutic_target | gene | 0.60 |
| RAS | therapeutic_target | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| DRD1 | therapeutic_target | gene | 0.60 |
| CX3CR1 | biomarker_for | gene | 0.60 |
| TAU | therapeutic_target | gene | 0.60 |
| C1QA | therapeutic_target | gene | 0.60 |
| P2RY12 | biomarker_for | gene | 0.60 |
| GPNMB | biomarker_for | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CLN3 in their description or question text
No additional research found